Novel antiviral C5-substituted pyrimidine acyclic nucleoside phosphonates selected as human thymidylate kinase substrates. 2011

Dimitri Topalis, and Ugo Pradère, and Vincent Roy, and Christophe Caillat, and Ahmed Azzouzi, and Julie Broggi, and Robert Snoeck, and Graciela Andrei, and Jay Lin, and Staffan Eriksson, and Julie A C Alexandre, and Chahrazade El-Amri, and Dominique Deville-Bonne, and Philippe Meyer, and Jan Balzarini, and Luigi A Agrofoglio
Groupe d'Enzymologie Moléculaire et Fonctionnelle, UR4-UPMC, Université Pierre et Marie Curie, Sorbonne Universités, Paris, France.

Acyclic nucleoside phosphonates (ANPs) are at the cornerstone of DNA virus and retrovirus therapies. They reach their target, the viral DNA polymerase, after two phosphorylation steps catalyzed by cellular kinases. New pyrimidine ANPs have been synthesized with unsaturated acyclic side chains (prop-2-enyl-, but-2-enyl-, pent-2-enyl-) and different substituents at the C5 position of the uracil nucleobase. Several derivatives in the but-2-enyl- series 9d and 9e, with (E) but not with (Z) configuration, were efficient substrates for human thymidine monophosphate (TMP) kinase, but not for uridine monophosphate-cytosine monophosphate (UMP-CMP) kinase, which is in contrast to cidofovir. Human TMP kinase was successfully crystallized in a complex with phosphorylated (E)-thymidine-but-2-enyl phosphonate 9e and ADP. The bis-pivaloyloxymethyl (POM) esters of (E)-9d and (E)-9e were synthesized and shown to exert activity against herpes virus in vitro (IC(50) = 3 μM) and against varicella zoster virus in vitro (IC(50) = 0.19 μM), in contrast to the corresponding inactive (Z) derivatives. Thus, their antiviral activity correlates with their ability to act as thymidylate kinase substrates.

UI MeSH Term Description Entries
D008024 Ligands A molecule that binds to another molecule, used especially to refer to a small molecule that binds specifically to a larger molecule, e.g., an antigen binding to an antibody, a hormone or neurotransmitter binding to a receptor, or a substrate or allosteric effector binding to an enzyme. Ligands are also molecules that donate or accept a pair of electrons to form a coordinate covalent bond with the central metal atom of a coordination complex. (From Dorland, 27th ed) Ligand
D008958 Models, Molecular Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures. Molecular Models,Model, Molecular,Molecular Model
D009703 Nucleoside-Phosphate Kinase An enzyme that catalyzes reversible reactions of a nucleoside triphosphate, e.g., ATP, with a nucleoside monophosphate, e.g., UMP, to form ADP and UDP. Many nucleoside monophosphates can act as acceptor while many ribo- and deoxyribonucleoside triphosphates can act as donor. EC 2.7.4.4. Nucleoside Monophosphate Kinases,Kinase, Nucleoside-Phosphate,Kinases, Nucleoside Monophosphate,Monophosphate Kinases, Nucleoside,Nucleoside Phosphate Kinase
D011355 Prodrugs A compound that, on administration, must undergo chemical conversion by metabolic processes before becoming the pharmacologically active drug for which it is a prodrug. Drug Precursor,Drug Precursors,Pro-Drug,Prodrug,Pro-Drugs,Precursor, Drug,Precursors, Drug,Pro Drug,Pro Drugs
D011741 Pyrimidine Nucleosides Pyrimidines with a RIBOSE attached that can be phosphorylated to PYRIMIDINE NUCLEOTIDES. Nucleosides, Pyrimidine
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D006564 Herpesviridae A family of enveloped, linear, double-stranded DNA viruses infecting a wide variety of animals. Subfamilies, based on biological characteristics, include: ALPHAHERPESVIRINAE; BETAHERPESVIRINAE; and GAMMAHERPESVIRINAE. Mouse Thymic Virus,Murid herpesvirus 3,Thymic Group Viruses,Herpesviruses,Mouse Thymic Viruses,Thymic Virus, Mouse,Thymic Viruses, Mouse
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000998 Antiviral Agents Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. Antiviral,Antiviral Agent,Antiviral Drug,Antivirals,Antiviral Drugs,Agent, Antiviral,Agents, Antiviral,Drug, Antiviral,Drugs, Antiviral
D013237 Stereoisomerism The phenomenon whereby compounds whose molecules have the same number and kind of atoms and the same atomic arrangement, but differ in their spatial relationships. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 5th ed) Molecular Stereochemistry,Stereoisomers,Stereochemistry, Molecular,Stereoisomer

Related Publications

Dimitri Topalis, and Ugo Pradère, and Vincent Roy, and Christophe Caillat, and Ahmed Azzouzi, and Julie Broggi, and Robert Snoeck, and Graciela Andrei, and Jay Lin, and Staffan Eriksson, and Julie A C Alexandre, and Chahrazade El-Amri, and Dominique Deville-Bonne, and Philippe Meyer, and Jan Balzarini, and Luigi A Agrofoglio
September 2017, Bioorganic & medicinal chemistry,
Dimitri Topalis, and Ugo Pradère, and Vincent Roy, and Christophe Caillat, and Ahmed Azzouzi, and Julie Broggi, and Robert Snoeck, and Graciela Andrei, and Jay Lin, and Staffan Eriksson, and Julie A C Alexandre, and Chahrazade El-Amri, and Dominique Deville-Bonne, and Philippe Meyer, and Jan Balzarini, and Luigi A Agrofoglio
July 2017, Antiviral research,
Dimitri Topalis, and Ugo Pradère, and Vincent Roy, and Christophe Caillat, and Ahmed Azzouzi, and Julie Broggi, and Robert Snoeck, and Graciela Andrei, and Jay Lin, and Staffan Eriksson, and Julie A C Alexandre, and Chahrazade El-Amri, and Dominique Deville-Bonne, and Philippe Meyer, and Jan Balzarini, and Luigi A Agrofoglio
July 2002, Antimicrobial agents and chemotherapy,
Dimitri Topalis, and Ugo Pradère, and Vincent Roy, and Christophe Caillat, and Ahmed Azzouzi, and Julie Broggi, and Robert Snoeck, and Graciela Andrei, and Jay Lin, and Staffan Eriksson, and Julie A C Alexandre, and Chahrazade El-Amri, and Dominique Deville-Bonne, and Philippe Meyer, and Jan Balzarini, and Luigi A Agrofoglio
September 2006, Antiviral research,
Dimitri Topalis, and Ugo Pradère, and Vincent Roy, and Christophe Caillat, and Ahmed Azzouzi, and Julie Broggi, and Robert Snoeck, and Graciela Andrei, and Jay Lin, and Staffan Eriksson, and Julie A C Alexandre, and Chahrazade El-Amri, and Dominique Deville-Bonne, and Philippe Meyer, and Jan Balzarini, and Luigi A Agrofoglio
January 1995, Postepy biochemii,
Dimitri Topalis, and Ugo Pradère, and Vincent Roy, and Christophe Caillat, and Ahmed Azzouzi, and Julie Broggi, and Robert Snoeck, and Graciela Andrei, and Jay Lin, and Staffan Eriksson, and Julie A C Alexandre, and Chahrazade El-Amri, and Dominique Deville-Bonne, and Philippe Meyer, and Jan Balzarini, and Luigi A Agrofoglio
November 2005, Nature reviews. Drug discovery,
Dimitri Topalis, and Ugo Pradère, and Vincent Roy, and Christophe Caillat, and Ahmed Azzouzi, and Julie Broggi, and Robert Snoeck, and Graciela Andrei, and Jay Lin, and Staffan Eriksson, and Julie A C Alexandre, and Chahrazade El-Amri, and Dominique Deville-Bonne, and Philippe Meyer, and Jan Balzarini, and Luigi A Agrofoglio
April 1995, Molecular pharmacology,
Dimitri Topalis, and Ugo Pradère, and Vincent Roy, and Christophe Caillat, and Ahmed Azzouzi, and Julie Broggi, and Robert Snoeck, and Graciela Andrei, and Jay Lin, and Staffan Eriksson, and Julie A C Alexandre, and Chahrazade El-Amri, and Dominique Deville-Bonne, and Philippe Meyer, and Jan Balzarini, and Luigi A Agrofoglio
January 2008, Casopis lekaru ceskych,
Dimitri Topalis, and Ugo Pradère, and Vincent Roy, and Christophe Caillat, and Ahmed Azzouzi, and Julie Broggi, and Robert Snoeck, and Graciela Andrei, and Jay Lin, and Staffan Eriksson, and Julie A C Alexandre, and Chahrazade El-Amri, and Dominique Deville-Bonne, and Philippe Meyer, and Jan Balzarini, and Luigi A Agrofoglio
November 2003, Toxicology and applied pharmacology,
Dimitri Topalis, and Ugo Pradère, and Vincent Roy, and Christophe Caillat, and Ahmed Azzouzi, and Julie Broggi, and Robert Snoeck, and Graciela Andrei, and Jay Lin, and Staffan Eriksson, and Julie A C Alexandre, and Chahrazade El-Amri, and Dominique Deville-Bonne, and Philippe Meyer, and Jan Balzarini, and Luigi A Agrofoglio
September 1994, Journal of medicinal chemistry,
Copied contents to your clipboard!